🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Premarket analyst action - healthcare new coverage

Published 09/19/2017, 07:25 AM
© Reuters.  Premarket analyst action - healthcare new coverage
ESRX
-
HSIC
-
PDCO
-
CAH
-
MCK
-
COR
-
CVS
-
WBA
-
MDRX
-
ATHN
-
CRL
-
MRTX
-
ATNXQ
-
  • CVS Health (NYSE:CVS) initiated with Outperform rating and $95 (14% upside) price target by RBC Capital Markets saying the company is at an inflection point in its life cycle and should merge with a managed care organization.
  • Charles River Laboratories (NYSE:CRL) initiated with Sector Perform rating with a $110 (3% upside) price target by RBC Capital Markets citing valuation.
  • AmerisourceBergen (NYSE:ABC) initiated with Sector Perform rating and $87 (7% upside) price target by RBC citing the need for more clarity that generic drug pricing has bottomed.
  • Allscripts (NASDAQ:MDRX) initiated with Outperform rating and $17 (24% upside) price target by RBC citing positive business execution, positioning for next-generation HCIT solutions and accretion from EIS acquisition.
  • Mirati Therapeutics (NASDAQ:MRTX) initiated with Outperform rating by Oppenheimer.
  • Express Scripts (NASDAQ:ESRX) initiated with Sector Perform rating and $68 (10% upside) price target by RBC citing the transition of Anthem's business and valuation.
  • Walgreens Boots Alliance (NASDAQ:WBA) initiated with Outperform rating and $96 (16% upside) price target by RBC citing improved execution, volume growth and accelerating EPS.
  • Cardinal Health (NYSE:CAH) initiated with Sector Perform rating and $72 (7% upside) price target by RBC citing the need for more clarity that generic drug pricing has bottomed.
  • athenahealth (NASDAQ:ATHN) initiated with Sector Perform rating and $153 (20% upside) price target by RBC citing valuation.
  • Athenex (NASDAQ:ATNX) initiated with Buy rating and $36 price target by Laidlaw.
  • Patterson Companies (NASDAQ:PDCO) initiated with Sector Perform rating and $42 (11% upside) price target by RBC citing the need for improved execution and valuation.
  • McKesson (NYSE:MCK) initiated with Sector Perform rating and $168 (14% upside) price target by RBC citing valuation and issues relating to drug pricing.
  • Henry Schein (NASDAQ:HSIC) initiated with Sector Perform rating and $91 (12% upside) price target by RBC citing valuation.
  • Source: Bloomberg
  • Now read: ALR's Stock Of The Week: The Cheapest Healthcare Stock?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.